Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Authors
Stefan Anker•Janet Schnee•Milton Packer
Journal
New England Journal of Medicine
Published
August 27, 2021
Abstract
Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.